- Home
- ONC
ONC
BeiGene Ltd. American Depositary Shares
as 02-21-2025 4:00pm EST
Upcoming Earnings Alert:
Get ready for potential market movements as BeiGene Ltd. American Depositary Shares ONC prepares to release earnings report on 27 Feb 2025.
| Founded: | 2010 | Country: | Cayman Islands |
| Employees: | N/A | City: | N/A |
| Market Cap: | 19.3B | IPO Year: | N/A |
| Target Price: | N/A | AVG Volume (30 days): | 357.2K |
| Analyst Decision: | N/A | Number of Analysts: | N/A |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -8.19 | EPS Growth: | N/A |
| 52 Week Low/High: | $126.97 - $260.98 | Next Earning Date: | 02-27-2025 |
| Revenue: | $3,351,304,621 | Revenue Growth: | 50.22% |
| Revenue Growth (this year): | 992.37% | Revenue Growth (next year): | 24.68% |
Latest BeiGene Ltd. American Depositary Shares News
ONC Breaking Stock News: Dive into ONC Ticker-Specific Updates for Smart Investing
Simply Wall St.
a day ago
US Stocks Trading Below Estimated Value In February 2025
Zacks
a day ago
BeiGene (ONC) Soars 3.2%: Is Further Upside Left in the Stock?
Simply Wall St.
2 days ago
High Growth Tech Stocks in the United States to Watch
Zacks
5 days ago
HRMY or ONC: Which Is the Better Value Stock Right Now?
Business Wire
9 days ago
BeiGene to Announce Fourth Quarter and Full Year 2024 Financial Results on February 27
Simply Wall St.
10 days ago
Is There An Opportunity With BeiGene, Ltd.'s (NASDAQ:ONC) 41% Undervaluation?
MT Newswires
15 days ago
Beigene Insider Sold Shares Worth $9,424,955, According to a Recent SEC Filing
Clinical Trials Arena
23 days ago
ImmunityBio and BeiGene partner on Phase III trial of NSCLC treatment combo
Compare ONC vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ONC BeiGene Ltd. American Depositary Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.